Eli Lilly (LLY) FY2011 results: revenue $24.3 billion, up 5.2% on the year
Eli Lilly & Co. (LLY) reported revenue of $24.3 billion for fiscal 2011, the year ended 31 December 2011, up 5.2% on the year before. Net income was $4.3 billion, down 14.2%, and diluted earnings per share $3.90. The figures are the company's own, from the 10-K it filed with the SEC on 24 February 2012.
Revenue
$24.3 billion
+5.2% on the year
FY2007FY2011
Operating margin
n/a
FY2007FY2011
Net income
$4.3 billion
-14.2% on the year
FY2007FY2011
Diluted EPS
$3.90
-14.8% on the year
FY2007FY2011
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2011
FY2010
FY2009
On the year
Last 8 years
Revenue
24,286
23,076
21,836
+5.2%
Cost of revenue
5,068
4,366
4,247
+16.1%
Gross profit
19,219
18,710
17,589
+2.7%
Gross margin
79.1%
81.1%
80.6%
Research and development
5,021
4,884
4,326
+2.8%
Selling, general and administrative
7,880
7,053
6,892
+11.7%
Interest expense
186
186
261
+0.3%
Pre-tax income
6,139
6,767
5,358
-9.3%
Income tax
1,002
1,456
1,029
-31.2%
Effective tax rate
16.3%
21.5%
19.2%
Net income
4,348
5,070
4,329
-14.2%
Net margin
17.9%
22.0%
19.8%
Diluted EPS
$3.90
$4.58
$3.94
-14.8%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2011
FY2010
FY2009
On the year
Last 8 years
Operating cash flow
7,234
6,857
4,336
+5.5%
Capital expenditure
672
694
765
-3.2%
Free cash flow
6,562
6,162
3,570
+6.5%
Free cash flow margin
27.0%
26.7%
16.4%
Cash from investing
-4,824
-3,160
143
Cash from financing
-2,370
-2,022
-5,534
Depreciation and amortisation
1,374
1,328
1,298
+3.4%
Share-based compensation
147
231
368
-36.2%
Buybacks
0.0
0.0
n/a
Dividends paid
2,180
2,165
2,152
+0.7%
Dividend per share
$1.96
$1.96
$1.96
0.0%
Diluted shares, weighted
1,114m
1,106m
1,098m
+0.7%
Balance sheet
$ million
FY2011
FY2010
FY2009
On the year
Last 8 years
Shareholders' equity
13,542
12,420
9,525
+9.0%
Non-controlling interest
-6.1
-7.5
n/a
Short-term borrowings
1,522
n/a
27.4
Debt
6,982
6,926
6,655
+0.8%
Other liabilities
11,620
11,662
11,253
-0.4%
Total liabilities and equity
33,660
31,001
27,461
+8.6%
Fixed assets
7,760
7,941
8,197
-2.3%
Goodwill
1,435
1,424
1,175
+0.8%
Investments
5,004
2,513
1,190
+99.1%
Cash and equivalents
5,922
5,993
4,463
-1.2%
Receivables
3,598
3,494
3,343
+3.0%
Inventory
2,300
2,518
2,850
-8.7%
Other assets
7,640
7,119
6,242
+7.3%
Total assets
33,660
31,001
27,461
+8.6%
10-K for the year ended 31 December 2011, filed 24 February 2012: the filing.